Screener
Solid Biosciences Inc. SLDB Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: Solid Biosciences Inc.’s 10-K, filed March 23, 2023.
- Filed
- Mar 23, 2023
- Fiscal year
- FY2022
- Accession
- 0000950170-23-009318
| Line item | Year Ended December 31, 2022 | Year Ended December 31, 2021 | Year Ended December 31, 2020 |
|---|---|---|---|
| Revenue | $8,094 | $13,620 | — |
| Operating expenses: | |||
| Research and development | 78,420 | 58,739 | 64,881 |
| General and administrative | 28,948 | 27,135 | 21,581 |
| Restructuring expense | 7,178 | — | 1,944 |
| Total operating expenses | 114,546 | 85,874 | 88,406 |
| Loss from operations | (106,452) | (72,254) | (88,406) |
| Other income, net: |
Item 16. Form 10-K Summary.
FAQ
- What is Solid Biosciences Inc.'s total revenue?
- Solid Biosciences Inc. (SLDB) reported total revenue of $2.02M in Q4 2022.
- How has Solid Biosciences Inc.'s total revenue changed year-over-year?
- Solid Biosciences Inc.'s total revenue decreased by 40.6% year-over-year, from $3.41M to $2.02M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Solid Biosciences Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude